Enovix (NASDAQ:ENVX) Shares Up 5.6% – Still a Buy?

Enovix Corporation (NASDAQ:ENVXGet Free Report)’s stock price was up 5.6% on Tuesday . The company traded as high as $8.66 and last traded at $8.57. Approximately 1,046,833 shares traded hands during mid-day trading, a decline of 82% from the average daily volume of 5,871,169 shares. The stock had previously closed at $8.11.

Wall Street Analysts Forecast Growth

A number of equities analysts have weighed in on ENVX shares. Benchmark decreased their target price on Enovix from $25.00 to $15.00 and set a “buy” rating for the company in a research report on Tuesday, April 15th. JPMorgan Chase & Co. cut their price target on Enovix from $10.00 to $9.00 and set an “overweight” rating for the company in a research note on Thursday, May 1st. TD Securities cut their price target on Enovix from $10.00 to $7.00 and set a “hold” rating for the company in a research note on Thursday, May 1st. Finally, B. Riley cut their price target on Enovix from $17.00 to $12.00 and set a “buy” rating for the company in a research note on Tuesday, April 29th. Three research analysts have rated the stock with a hold rating and eight have issued a buy rating to the company. According to MarketBeat, Enovix has a consensus rating of “Moderate Buy” and a consensus price target of $17.27.

Get Our Latest Stock Analysis on ENVX

Enovix Trading Up 4.8%

The stock has a 50 day moving average of $7.45 and a 200-day moving average of $8.87. The company has a market capitalization of $1.63 billion, a P/E ratio of -6.59 and a beta of 2.00. The company has a current ratio of 4.68, a quick ratio of 4.49 and a debt-to-equity ratio of 0.71.

Institutional Inflows and Outflows

A number of hedge funds have recently made changes to their positions in ENVX. Rhumbline Advisers grew its stake in shares of Enovix by 4.1% during the 4th quarter. Rhumbline Advisers now owns 219,070 shares of the company’s stock valued at $2,381,000 after acquiring an additional 8,564 shares during the period. Atria Wealth Solutions Inc. boosted its stake in Enovix by 11.6% in the 4th quarter. Atria Wealth Solutions Inc. now owns 21,594 shares of the company’s stock worth $235,000 after purchasing an additional 2,250 shares during the period. Private Advisor Group LLC boosted its stake in Enovix by 17.4% in the 4th quarter. Private Advisor Group LLC now owns 117,251 shares of the company’s stock worth $1,275,000 after purchasing an additional 17,351 shares during the period. Concurrent Investment Advisors LLC boosted its stake in Enovix by 79.0% in the 4th quarter. Concurrent Investment Advisors LLC now owns 63,481 shares of the company’s stock worth $690,000 after purchasing an additional 28,023 shares during the period. Finally, Y Intercept Hong Kong Ltd bought a new position in Enovix in the 4th quarter worth approximately $1,380,000. 50.92% of the stock is currently owned by institutional investors.

Enovix Company Profile

(Get Free Report)

Enovix Corporation designs develops and manufactures silicon-anode lithium-ion batteries. It serves wearables and IoT, smartphone, laptops and tablets, industrial and medical, and electric vehicles industries. The company was founded in 2007 and is headquartered in Fremont, California.

See Also

Receive News & Ratings for Enovix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enovix and related companies with MarketBeat.com's FREE daily email newsletter.